Your browser doesn't support javascript.
loading
BDNF release and signaling are required for the antidepressant actions of GLYX-13.
Kato, T; Fogaça, M V; Deyama, S; Li, X-Y; Fukumoto, K; Duman, R S.
Afiliación
  • Kato T; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
  • Fogaça MV; Drug Development Research Laboratories, Sumitomo Dainippon Pharma, New Haven, CT, USA.
  • Deyama S; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
  • Li XY; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
  • Fukumoto K; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
  • Duman RS; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Mol Psychiatry ; 23(10): 2007-2017, 2018 10.
Article en En | MEDLINE | ID: mdl-29203848

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oligopéptidos / Factor Neurotrófico Derivado del Encéfalo Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Mol Psychiatry Asunto de la revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oligopéptidos / Factor Neurotrófico Derivado del Encéfalo Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Mol Psychiatry Asunto de la revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos